This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Shionogi Company Limited. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2018 - 2019)
- Toyonaka, JP (2019 - 2020)
Company Filing History:
Years Active: 2018-2020
Title: Keisuke Miyazaki: Innovator in Antifungal Compounds
Introduction
Keisuke Miyazaki is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal compounds. With a total of 4 patents to his name, Miyazaki's work has the potential to impact medical treatments significantly.
Latest Patents
Miyazaki's latest patents include a Polyene macrolide derivative, specifically an Amphotericin B derivative. This invention details a compound where the 16th position (X) can be a urea structure, cyclic structure, hydroxyalkyl, or substituted monoalkylcarbamoyl. The compound exhibits antifungal activity, showcasing its potential in treating fungal infections.
Career Highlights
Miyazaki is currently associated with Shionogi Company Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficacy of existing compounds and developing new solutions for challenging medical conditions.
Collaborations
Miyazaki collaborates with esteemed colleagues, including Kenji Takaya and Takafumi Ohara. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Keisuke Miyazaki's contributions to antifungal research and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile